Top of the morning to you. A bit of slush has descended on the Pharmalot corporate campus overnight, which means the short people have some additional time to snooze before we deposit them at their schoolhouses. Nothing like a few quiet moments, yes? Just the same, there is work to be done. Today promises to be a busy one and we trust you can related. So here are a few tidbits to get you started. Hope all goes well and do stay in touch...
Dendreon Pays $40M To Settle Class-Action Shareholder Suit (Seattle Times)
Novo Nordisk Obesity Drug Test Results Underwhelm Investors (Reuters)
AbbVie CEO Gonzalez Got $7.9M in 2012 (Dow Jones)
UK's MHRA Says Preclinical Data Fraud Is Rare (Outsourcing Pharma)
Healthcare Reform And Budget Cuts Will Hit Biotech: Fidelity Manager (Reuters)
FDA To Boost Inspections In China (InPharma Technologist)
Quebec Attacked For 'Dangerous' Drug Pricing Plan (Pharma Times)
Walgreens, Alliance Boots And AmerisourceBergen Form Partnership (Bloomberg News)
Australia Criticized For Overpaying For Drugs (Pharma Times)
EDITOR'S NOTE: Please check this post for additional stories during the day
snowfall pic thx to mdid on flickr
1 Comment